Junporn Kongwatcharapong

Dr. Junporn Kongwatcharapong


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2019 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
KSKannikar Semcharoen
Kannikar Semcharoen
SSSajja Supornpun
Sajja Supornpun
SNSurakit Nathisuwan
Surakit Nathisuwan
JKJunporn Kongwatcharapong
Junporn Kongwatcharapong

27 March 2020 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
SSSayamon Sukkha
Sayamon Sukkha
WRWipharak Rattanavipanon
Wipharak Rattanavipanon
BCBenjawan Chamroenwit
Benjawan Chamroenwit
MSMalita Sanganurak
Malita Sanganurak
SNSurakit Nathisuwan
Surakit Nathisuwan
JKJunporn Kongwatcharapong
Junporn Kongwatcharapong

28 August 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
PWPhannita Wattanaruengchai
Phannita Wattanaruengchai
SNSurakit Nathisuwan
Surakit Nathisuwan
WRWipharak Rattanavipanon
Wipharak Rattanavipanon
SCSuvatna Chulavatnatol
Suvatna Chulavatnatol
JKJunporn Kongwatcharapong
Junporn Kongwatcharapong
GLGregory Y.H. Lip
Gregory Y.H. Lip

21 March 2023 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
PWPhannita Wattanaruengchai
Phannita Wattanaruengchai
JKJunporn Kongwatcharapong
Junporn Kongwatcharapong
SNSurakit Nathisuwan
Surakit Nathisuwan
Introduction: Data regarding drug‐related problems (DRPs) and pharmacist's role in the cardiovascular intensive care units (CICU) from low‐ to middle‐income countries (LMIC) are limited.Objective: The study aimed to characterize the DRP and interventions provided by clinical pharmacists in the CICU settings.Method: A retrospective, cross‐sectional study was conducted in patients admitted to CICU of a tertiary‐care hospital in Thailand during January 2021 to March 2022 was performed. Data were collected from patient's medical records and pharmacy service records. DRPs were categorized according to the Pharmaceutical Care Network Europe classification. Two board‐certified pharmacotherapy specialists, pharmacy residents, and trained clinical pharmacists staffed the units 5 days a week. The pharmacist team conducted a medication review and provided interventions to the cardiology team either verbally during the ward round or in writing, as appropriate. Pharmacist interventions were categorized into two groups including retrospective intervention (interventions made to resolve DRPs after an order was made) and prospective interventions (interventions made prior to ordering process). Outcome measures were (1) number of DRPs identified; (2) category of DRPs; (3) number interventions; and (4) acceptance rate of interventions by the medical team.Results: Among 576 patients admitted to the CICU, 345 DRPs were identified in 203 patients. The pharmacist team provided a total of 790 interventions including 345 retrospective interventions to resolve DRPs and 445 prospective interventions to guide medication use prior to the ordering process. The most frequent intervention was related to dosage adjustment, drug administration, adding drugs for existing conditions, and suggesting laboratory monitoring. The acceptance rate of the pharmacist intervention was 97.4%, most of which led to changes in drug therapy.Conclusion: DRPs in CICU settings are common. Trained clinical pharmacists can effectively resolve DRPs and provide recommendations to improve quality of care through both clinical and distribution functions.

1 September 2024 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
APAutchariya Poungkaew
Autchariya Poungkaew
TTThitipong Tankumpuan
Thitipong Tankumpuan
CRChontira Riangkam
Chontira Riangkam
JKJunporn Kongwatcharapong
Junporn Kongwatcharapong
TDTassanee Daekunthod
Tassanee Daekunthod
BKBinu Koirala
Binu Koirala
Introduction: Older people mostly found unable to adhere with warfarin treatment guidelines. The health service system is challenged in order to improve medication adherence in older population under limited health resources. The purpose of this study was to explore health systems factors on warfarin adherence in older population, particularly in resources constraint setting. Methods: This study was a cross-sectional predictive study that enrolled older people who experienced atrial fibrillation (AF) and treated by warfarin, aged 60 years and over, and followed up at the warfarin clinic. Results: A total of 197 participants with the mean age of 72.03 years (SD = 8.84) was recruited. Almost of them (85.8%) reported adhered to warfarin prescription. More than a half (60.5%) were able to report their targeted INR. Participants who stayed with the family had 5.54 times (95% CI 1.79– 19.33), took regular daily dose warfarin had 5.07 times (95% CI 1.05– 24.49), perceived targeted INR had 2.94 times (95% CI 1.04– 8.29), and received family support had 1.33 times (95% CI 1.11– 1.60) increased odds of warfarin adherence than those who did not. Participants who perceived a barrier to taking medication had 0.93 times decreased odds of warfarin adherence than those who did not (95% CI 0.86– 0.99). Conclusion: Healthcare system should encourage family to support the older population with AF in order to increase warfarin adherence. Future research should develop intervention combining family support to promote warfarin adherence.

26 July 2024
Verified
Open access
ALApisara Lohachatinante
Apisara Lohachatinante
NKNuttanun Kittikunkanyakit
Nuttanun Kittikunkanyakit
SSSayamon Sukkha
Sayamon Sukkha
SCSupatat Chumnumwat
Supatat Chumnumwat
RCRattana Chawanasuntharapot
Rattana Chawanasuntharapot
JKJunporn Kongwatcharapong
Junporn Kongwatcharapong